Shandong Luxi Pharmaceutical Co., Ltd.
FDA inspection history in Heze, China, 2019
- 1
- Form 483
Every document, by year
- Form 483
2019: one Form 483.
The story so far
Built from the dates and citations on the documents themselves.
- 2019One Form 483, at Heze, China.
Cited most
Across all Shandong Luxi Pharmaceutical Co. observations on file
- 21 CFR 211.68Automatic, mechanical, and electronic equipment3
- 21 CFR 211.194Laboratory records2
- 21 CFR 211.160General requirements1
- 21 CFR 211.166Stability testing1
The complete Shandong Luxi Pharmaceutical Co. file.
All 1 documents as original PDFs. For supplier audits, diligence and inspection prep.
Sites
Heze, China
One Form 483 · 2019 · 6 observations
Latest: Form 483, Jul 24, 2019 →
Documents
1 on file, newest first| Date | Document | Location | Observations | Price |
|---|---|---|---|---|
| 2019-07-24 | 483 Form 483 | Heze, China | 6 | $99 |
Investigators on these documents
FEI number 3011615110 · most recent document Jul 24, 2019
About Shandong Luxi Pharmaceutical Co., Ltd.
How many FDA Form 483s has Shandong Luxi Pharmaceutical Co., Ltd. received?
FDA Intel has 1 Form 483 on file for Shandong Luxi Pharmaceutical Co., Ltd.; the most recent is dated Jul 24, 2019.
When was Shandong Luxi Pharmaceutical Co., Ltd. last inspected by FDA?
The most recent FDA inspection document on file for Shandong Luxi Pharmaceutical Co., Ltd. is a Form 483 dated Jul 24, 2019, for the site in Heze, China.
What did FDA cite at Shandong Luxi Pharmaceutical Co., Ltd.?
The regulations cited most in the observations on file for Shandong Luxi Pharmaceutical Co., Ltd. are 21 CFR 211.68 (Automatic, mechanical, and electronic equipment), 3 times; 21 CFR 211.194 (Laboratory records), 2 times; 21 CFR 211.160 (General requirements), 1 time.